(VIANEWS) - Moderna (MRNA), BRF S.A. (BRFS), BorgWarner (BWA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Moderna (MRNA)
7189.7% sales growth and 21.83% return on equity
Moderna's sales growth this year is expected to be 2180.2% and a negative 16.2% for next year.
Year-on-year quarterly revenue growth grew by 24112.5%, now sitting on 2.73B for the twelve trailing months.
Volume
Today's last reported volume for Moderna is 6864850 which is 28.2% below its average volume of 9560550.
Moderna's sales growth for the next quarter is 7189.7%. The company's growth estimates for the ongoing quarter and the next is 2048.4% and 1439%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.83%.
Volatility
Moderna's last day, last week, and last month's current volatility was 0.01%, 2.17%, and 2.48%, respectively.
Moderna's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.24% (day), 5.23% (last week), and 5.44% (last month), respectively.
Moderna's Stock Yearly Top and Bottom Value
Moderna's stock is valued at $239.34 at 20:22 EST, under its 52-week high of $245.70 and way above its 52-week low of $54.21.
Moderna's Moving Average
Moderna's value is way higher than its 50-day moving average of $205.20 and way higher than its 200-day moving average of $161.63.Previous days news about Moderna(MRNA)
According to MarketWatch on Thursday, 8 July, "Without a vaccination program, by the end of June 2021 there would have been approximately 279,000 additional deaths and up to 1.25 million additional hospitalizations," in the U.S., with German partner BioNTech and by Moderna , and a single-dose regimen developed by Johnson & Johnson - offer protection against all variants, including delta, but many Americans have not yet been inoculated, because they lack access or are refusing for political or religious reasons."
According to Bloomberg Quint on Friday, 9 July, "It will also give a third shot to 1.47 million healthcare workers using Moderna Inc. vaccine starting next week in a bid to boost their protection against the virus, said Health Minister Budi Gunadi Sadikin. "
According to Bloomberg Quint on Thursday, 8 July, "Research shows that the delta mutation is powerful enough to make even mRNA shots from BioNTech SE and Moderna Inc. less effective, bringing down protection to below 90%. "
According to Bloomberg Quint on Thursday, 8 July, "In the U.S., over 184 million doses of the Pfizer vaccine have been administered so far, outpacing 135 million doses of Moderna Inc.'s vaccine that have been used in the country, according to the Centers for Disease Control and Prevention."
According to Bloomberg Quint on Thursday, 8 July, "Vaccine minister Taro Kono revealed on Tuesday that the number of Moderna shots coming into the country through end-June had been cut to less than half of an initial target, but the remaining doses will arrive by the end of September."
2. BRF S.A. (BRFS)
58.3% sales growth and 16.39% return on equity
BRF S.A. focuses on raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, and other products.
BRF S.A.'s sales growth this year is expected to be 14% and 5.5% for next year.
Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 39.47B for the twelve trailing months.
Volume
Today's last reported volume for BRF S.A. is 4938680 which is 5.94% above its average volume of 4661680.
BRF S.A.'s sales growth for the next quarter is 58.3%. The company's growth estimates for the present quarter and the next is 300% and negative -28.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.39%.
Volatility
BRF S.A.'s last day, last week, and last month's current volatility was 0.83%, 4.91%, and 2.69%, respectively.
BRF S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.01% (day), 6.95% (last week), and 4.07% (last month), respectively.
BRF S.A.'s Stock Yearly Top and Bottom Value
BRF S.A.'s stock is valued at $4.99 at 20:22 EST, way below its 52-week high of $6.08 and way above its 52-week low of $2.85.
BRF S.A.'s Moving Average
BRF S.A.'s worth is under its 50-day moving average of $5.39 and way higher than its 200-day moving average of $4.48.3. BorgWarner (BWA)
48% sales growth and 9.1% return on equity
BorgWarner Inc. provides solutions for combustion, hybrid, and electric vehicles worldwide.
BorgWarner's sales growth this year is anticipated to be 48.8% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 75.9%, now sitting on 11.9B for the twelve trailing months.
Volume
Today's last reported volume for BorgWarner is 1730600 which is 4.56% below its average volume of 1813230.
BorgWarner's sales growth for the next quarter is 48%. The company's growth estimates for the ongoing quarter and the next is 678.6% and 13.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.1%.
Volatility
BorgWarner's last day, last week, and last month's current volatility was 1.45%, 1.00%, and 1.81%, respectively.
BorgWarner's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.81% (day), 2.20% (last week), and 2.70% (last month), respectively.
BorgWarner's Stock Yearly Top and Bottom Value
BorgWarner's stock is valued at $46.62 at 20:22 EST, way under its 52-week high of $55.55 and way higher than its 52-week low of $34.30.
BorgWarner's Moving Average
BorgWarner's value is below its 50-day moving average of $50.52 and below its 200-day moving average of $46.75.4. Coda Octopus Group (CODA)
34.7% sales growth and 15.86% return on equity
Coda Octopus Group, Inc., together with its subsidiaries, develops and sells underwater technologies and equipment for imaging, mapping, defense, and survey applications in the Americas, Europe, Australia, Asia, the Middle East, and Africa.
Coda Octopus Group's sales growth this year is expected to be 12.4% and 28.3% for next year.
Year-on-year quarterly revenue growth grew by 63.4%, now sitting on 20.5M for the twelve trailing months.
Volume
Today's last reported volume for Coda Octopus Group is 3396 which is 83.35% below its average volume of 20392.
Coda Octopus Group's sales growth is a negative 0% for the present quarter and 34.7% for the next. The company's growth estimates for the ongoing quarter and the next is 33.3% and 27.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.86%.
Volatility
Coda Octopus Group's last day, last week, and last month's current volatility was 1.30%, 2.99%, and 2.10%, respectively.
Coda Octopus Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.15% (day), 4.60% (last week), and 4.45% (last month), respectively.
Coda Octopus Group's Stock Yearly Top and Bottom Value
Coda Octopus Group's stock is valued at $8.96 at 20:22 EST, way below its 52-week high of $10.17 and way above its 52-week low of $4.91.
Coda Octopus Group's Moving Average
Coda Octopus Group's worth is higher than its 50-day moving average of $8.89 and way above its 200-day moving average of $7.97.5. Coastal Financial Corporation (CCB)
30.5% sales growth and 13.46% return on equity
Coastal Financial Corporation operates as the bank holding company for Coastal Community Bank that provides various banking products and services to small to medium-sized businesses, professionals, and individuals in the Puget Sound region in Washington.
Coastal Financial Corporation's sales growth this year is anticipated to be 28.1% and 10% for next year.
Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 64.62M for the twelve trailing months.
Volume
Today's last reported volume for Coastal Financial Corporation is 12248 which is 52.3% below its average volume of 25677.
Coastal Financial Corporation's sales growth is a negative 0% for the current quarter and 30.5% for the next. The company's growth estimates for the present quarter and the next is 60% and 32.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.46%.
Volatility
Coastal Financial Corporation's last day, last week, and last month's current volatility was 0.16%, 1.27%, and 2.04%, respectively.
Coastal Financial Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.92% (day), 4.46% (last week), and 5.29% (last month), respectively.
Coastal Financial Corporation's Stock Yearly Top and Bottom Value
Coastal Financial Corporation's stock is valued at $28.84 at 20:22 EST, way below its 52-week high of $33.76 and way higher than its 52-week low of $11.58.
Coastal Financial Corporation's Moving Average
Coastal Financial Corporation's worth is under its 50-day moving average of $29.97 and above its 200-day moving average of $26.89.6. Sociedad Quimica y Minera S.A. (SQM)
28% sales growth and 8.96% return on equity
Sociedad QuÃmica y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services.
Sociedad Quimica y Minera S.A.'s sales growth this year is anticipated to be 22.9% and 19.8% for next year.
Year-on-year quarterly revenue growth grew by 34.8%, now sitting on 1.95B for the twelve trailing months.
Volume
Today's last reported volume for Sociedad Quimica y Minera S.A. is 949002 which is 29.2% below its average volume of 1340300.
Sociedad Quimica y Minera S.A.'s sales growth is a negative 0% for the present quarter and 28% for the next. The company's growth estimates for the current quarter and the next is 76.5% and 3500%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.96%.
Volatility
Sociedad Quimica y Minera S.A.'s last day, last week, and last month's current volatility was 1.98%, 1.19%, and 2.60%, respectively.
Sociedad Quimica y Minera S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.66% (day), 3.71% (last week), and 4.27% (last month), respectively.
Sociedad Quimica y Minera S.A.'s Stock Yearly Top and Bottom Value
Sociedad Quimica y Minera S.A.'s stock is valued at $47.91 at 20:22 EST, way under its 52-week high of $60.74 and way above its 52-week low of $28.05.
Sociedad Quimica y Minera S.A.'s Moving Average
Sociedad Quimica y Minera S.A.'s worth is higher than its 50-day moving average of $45.45 and under its 200-day moving average of $51.63.7. Rollins (ROL)
8.1% sales growth and 34.67% return on equity
Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers.
Rollins's sales growth this year is expected to be 8.9% and 5.9% for next year.
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 2.21B for the twelve trailing months.
Volume
Today's last reported volume for Rollins is 700574 which is 45.83% below its average volume of 1293340.
Rollins's sales growth for the next quarter is 8.1%. The company's growth estimates for the present quarter and the next is 20% and 11.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.67%.
Rollins's Stock Yearly Top and Bottom Value
Rollins's stock is valued at $35.39 at 20:22 EST, way below its 52-week high of $43.00 and way higher than its 52-week low of $29.49.